Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - STOCK-BASED COMPENSATION
Stock-based Compensation NVAX - Novavax, Inc.
85.4 M
LAST VALUE
-31.82%
2 YEAR CAGR
36.05%
5 YEAR CAGR
42.46%
10 YEAR CAGR